Largest health care pharmaceutical companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 health care pharmaceutical companies ranked by total liabilities, at NOK 1.34T, ahead of Pfizer (NOK 1.19T) and Johnson & Johnson (NOK 1.15T). Figures as of 19 Nov 2026, 20:53 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieNOK 1.34T
- Median
- NOK 20.4B
- Combined market value
- NOK 48.53T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | NOK 1.34T | NOK 4.9T | NOK 2,770.14 | 0.83% down | 25% up | ||
| 2 | PfizerPFE · Health Care | NOK 1.19T | NOK 1.54T | NOK 269.46 | 1.67% down | 15% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | NOK 1.15T | NOK 6.28T | NOK 2,609.14 | 2.04% down | 34% up | ||
| 4 | Eli LillyLLY · Health Care | NOK 839.3B | NOK 11.77T | NOK 13,209.10 | 2.19% down | 33% up | ||
| 5 | Merck & CoMRK · Health Care | NOK 822.4B | NOK 3.2T | NOK 1,299.25 | 3.45% down | 45% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | NOK 698.6B | NOK 1.17T | NOK 570.27 | 1.96% down | 30% up | ||
| 7 | AstraZenecaAZN · Health Care | NOK 638.3B | NOK 2.66T | NOK 1,712.86 | 1.89% down | 1% up | ||
| 8 | NovartisNVS · Health Care | NOK 629B | NOK 2.79T | NOK 1,478.95 | 2.44% down | 25% up | ||
| 9 | SanofiSNY · Health Care | NOK 597B | NOK 1.08T | NOK 449.90 | 2.24% down | 4% down | ||
| 10 | GSKGSK · Health Care | NOK 585.5B | NOK 936.8B | NOK 467.38 | 1.49% down | 5% up | ||
| 11 | Novo NordiskNVO · Health Care | NOK 505.6B | NOK 1.67T | NOK 379.97 | 1.33% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | NOK 494.3B | NOK 670.1B | NOK 209.74 | 0.96% up | 51% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | NOK 331.5B | NOK 1.76T | NOK 1,017.97 | 0.24% down | 16% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | NOK 320.7B | NOK 442.6B | NOK 379.29 | 8.04% down | 74% up | ||
| 15 | ViatrisVTRS · Health Care | NOK 219.6B | NOK 222.7B | NOK 194.26 | 1.92% down | 99% up | ||
| 16 | GrifolsGRFS · Health Care | NOK 131.2B | NOK 54.7B | NOK 80.33 | 2.89% down | 0% up | ||
| 17 | ZoetisZTS · Health Care | NOK 118.5B | NOK 322B | NOK 792.56 | 5.17% down | 26% down | ||
| 18 | Royalty PharmaRPRX · Health Care | NOK 96.7B | NOK 380.2B | NOK 661.20 | 1.41% down | 79% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | NOK 90.8B | NOK 937.7B | NOK 9,064.51 | 1.84% down | 28% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | NOK 71.7B | NOK 147.3B | NOK 2,294.56 | 5.18% down | 41% up | ||
| 21 | GenmabGMAB · Health Care | NOK 68.6B | NOK 309B | NOK 501.17 | 0.68% up | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | NOK 68.1B | NOK 1.29T | NOK 5,101.18 | 2.64% down | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | NOK 66.5B | NOK 129.4B | NOK 258.86 | 0.73% down | 26% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | NOK 40.8B | NOK 194.1B | NOK 1,449.26 | 0.68% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | NOK 37.4B | NOK 446.4B | NOK 3,907.80 | 0.86% down | 16% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | NOK 35.9B | NOK 72.6B | NOK 208.52 | 2.42% down | 90% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | NOK 30.3B | NOK 47.8B | NOK 572.03 | 2.76% down | 21% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | NOK 29.6B | NOK 44.4B | NOK 266.73 | 0.29% down | 63% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | NOK 29.4B | NOK 149.2B | NOK 765.80 | 0.51% up | 21% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 20.7B | NOK 121.3B | NOK 145.52 | 0.53% down | 8% up | ||
| 31 | CytokineticsCYTK · Health Care | NOK 20.4B | NOK 70.2B | NOK 503.96 | 0.55% up | 19% down | ||
| 32 | Ascendis PharmaASND · Health Care | NOK 15.9B | NOK 163.9B | NOK 2,498.19 | 5.38% down | 29% up | ||
| 33 | InsmedINSM · Health Care | NOK 14.9B | NOK 309.6B | NOK 1,411.03 | 20.60% up | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | NOK 14.7B | NOK 116.5B | NOK 601.23 | 0.21% up | 17% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 8.6B | NOK 60.4B | NOK 427.58 | 1.55% up | 13% up | ||
| 36 | United TherapeuticsUTHR · Health Care | NOK 7.7B | NOK 233.7B | NOK 5,486.47 | 2.70% down | 22% up | ||
| 37 | Legend BiotechLEGN · Health Care | NOK 7.1B | NOK 30.6B | NOK 157.83 | 0.55% down | 41% down | ||
| 38 | AlkermesALKS · Health Care | NOK 6.5B | NOK 76B | NOK 452.00 | 1.22% down | 66% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 6.4B | NOK 90.3B | NOK 3,885.51 | 0.06% down | 27% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | NOK 5.9B | NOK 69.9B | NOK 1,328.50 | 1.51% up | 6% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | NOK 5.3B | NOK 56.4B | NOK 2,819.66 | 3.35% down | 50% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | NOK 5.2B | NOK 60.9B | NOK 933.10 | 3.30% up | 34% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | NOK 4.8B | NOK 45.5B | NOK 473.92 | 3.41% down | 45% up | ||
| 44 | Roivant SciencesROIV · Health Care | NOK 4.1B | NOK 277.6B | NOK 383.14 | 1.29% up | 91% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | NOK 4.1B | NOK 96.5B | NOK 638.34 | 1.15% down | 117% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | NOK 2.9B | NOK 47.5B | NOK 273.22 | 0.59% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 2.1B | NOK 79.6B | NOK 1,148.55 | 1.21% down | 18% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 1.9B | NOK 72.1B | NOK 917.86 | 1.13% down | 129% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | NOK 1.8B | NOK 69.6B | NOK 636.39 | 3.88% down | 10% down | ||
| 50 | ABIVAXABVX · Health Care | NOK 1.4B | NOK 69.1B | NOK 789.19 | 3.61% down | 32% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | NOK 1.1B | NOK 39.6B | NOK 289.19 | 1.68% up | 168% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | NOK 901.7M | NOK 83.3B | NOK 104.21 | 1.62% up | 36% down | ||
| 53 | ErascaERAS · Health Care | NOK 693.3M | NOK 49.4B | NOK 140.74 | 4.72% up | 395% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | NOK 610.9M | NOK 91.2B | NOK 960.54 | 3.07% down | 332% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | NOK 583.8M | NOK 86B | NOK 3,078.18 | 3.27% up | 86% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | NOK 522.3M | NOK 80B | NOK 1,225.71 | 1.31% down | 51% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | NOK 366.5M | NOK 46.9B | NOK 833.38 | 1.61% up | 108% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | NOK 296.4M | NOK 44B | NOK 402.33 | 0.42% down | 86% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | NOK 163M | NOK 65B | NOK 958.74 | 2.53% up | 255% up | ||
| 60 | Belite BioBLTE · Health Care | NOK 98.3M | NOK 60.6B | NOK 1,491.31 | 2.26% down | 43% up | ||
| 61 | VeradermicsMANE · Health Care | NOK 89.4M | NOK 51.4B | NOK 1,218.82 | 0.05% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7666 NOK).
Questions and answers
Which health care pharmaceutical companies rank first by total liabilities?
AbbVie (NOK 1.34T), Pfizer (NOK 1.19T) and Johnson & Johnson (NOK 1.15T) are the top three of the 61 health care pharmaceutical companies ranked by total liabilities as of 19 Nov 2026, 20:53 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by total liabilities.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by total liabilities have a combined market value of NOK 48.53T as of 19 Nov 2026, 20:53 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by total liabilities”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.